|
1
|
Leddy LR and Holmes RE: Chondrosarcoma of
bone. Cancer Treat Res. 162:117–130. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gelderblom H, Hogendoorn PC, Dijkstra SD,
van Rijswijk CS, Krol AD, Taminiau AH and Bovée JV: The clinical
approach towards chondrosarcoma. Oncologist. 13:320–329. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Van Gompel JJ and Janus JR: Chordoma and
chondrosarcoma. Otolaryngol Clin North Am. 48:501–514. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yuan J, Dutton CM and Scully SP: RNAi
mediated MMP-1 silencing inhibits human chondrosarcoma invasion. J
Orthop Res. 32:1467–1474. 2005. View Article : Google Scholar
|
|
5
|
Sakimura R, Tanaka K, Yamamoto S,
Matsunobu T, Li X, Hanada M, Okada T, Nakamura T, Li Y and Iwamoto
Y: The effects of histone deacetylase inhibitors on the induction
of differentiation in chondrosarcoma cells. Clin Cancer Res.
13:275–282. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Taniwaki K, Fukamachi H, Komori K, Ohtake
Y, Nonaka T, Sakamoto T, Shiomi T, Okada Y, Itoh T, Itohara S, et
al: Stroma-derived matrix metalloproteinase (MMP)-2 promotes
membrane type 1-MMP-dependent tumor growth in mice. Cancer Res.
67:4311–4319. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Park JM, Kim A, Oh JH and Chung AS:
Methylseleninic acid inhibits PMA-stimulated pro-MMP-2 activation
mediated by MT1-MMP expression and further tumor invasion through
suppression of NF-kappaB activation. Carcinogenesis. 28:837–847.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chiu YC, Yang RS, Hsieh KH, Fong YC, Way
TD, Lee TS, Wu HC, Fu WM and Tang CH: Stromal cell-derived factor-1
induces matrix metalloprotease-13 expression in human chondrocytes.
Mol Pharmacol. 72:695–703. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Brown GT and Murray GI: Current
mechanistic insights into the roles of matrix metalloproteinases in
tumour invasion and metastasis. J Pathol. 237:273–281. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Moon JW, Choi JH, Lee SK, Lee YW, Lee JO,
Kim N, Lee HJ, Seo JS, Kim J, Kim HS, et al: Promoter
hypermethylation of membrane type 3 matrix metalloproteinase is
associated with cell migration in colorectal adenocarcinoma. Cancer
Genet. 208:261–270. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang X, Yin P, DI D, Luo G, Zheng L, Wei
J, Zhang J, Shi Y, Zhang J and Xu N: IL-6 regulates MMP-10
expression via JAK2/STAT3 signaling pathway in a human lung
adenocarcinoma cell line. Anticancer Res. 29:4497–4501.
2009.PubMed/NCBI
|
|
12
|
Galoian KA, Garamszegi N, Garamszegi SP
and Scully SP: Molecular mechanism of tenascin-C action on matrix
metalloproteinase-1 invasive potential. Exp Biol Med (Maywood).
232:515–522. 2007.PubMed/NCBI
|
|
13
|
Pritchard AL and Hayward NK: Molecular
pathways: Mitogen-activated protein kinase pathway mutations and
drug resistance. Clin Cancer Res. 19:2301–2309. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Klein AM, Zaganjor E and Cobb MH:
Chromatin-tethered MAPKs. Curr Opin Cell Biol. 25:272–277. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chen PN, Hsieh YS, Chiou HL and Chu SC:
Silibinin inhibits cell invasion through inactivation of both
PI3K-Akt and MAPK signaling pathways. Chem Biol Interact.
156:141–150. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ozen E, Gozukizil A, Erdal E, Uren A,
Bottaro DP and Atabey N: Heparin inhibits Hepatocyte Growth Factor
induced motility and invasion of hepatocellular carcinoma cells
through early growth response protein 1. PLoS One. 7:e427172012.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lin CW, Hou WC, Shen SC, Juan SH, Ko CH,
Wang LM and Chen YC: Quercetin inhibition of tumor invasion via
suppressing PKC/ERK/AP-1-dependent matrix metalloproteinase-9
activation in breast carcinoma cells. Carcinogenesis. 29:1807–1815.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhao HJ, Liu T, Mao X, Han SX, Liang RX,
Hui LQ, Cao CY, You Y and Zhang LZ: Fructus phyllanthi tannin
fraction induces apoptosis and inhibits migration and invasion of
human lung squamous carcinoma cells in vitro via MAPK/MMP pathways.
Acta Pharmacol Sin. 36:758–768. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cohen M, Meisser A, Haenggeli L and
Bischof P: Involvement of MAPK pathway in TNF-alpha-induced MMP-9
expression in human trophoblastic cells. Mol Hum Reprod.
12:225–232. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative pcr and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Iwamoto Y: Diagnosis and treatment of
Ewing's sarcoma. Jpn J Clin Oncol. 37:79–89. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tan TW, Yang WH, Lin YT, Hsu SF, Li TM,
Kao ST, Chen WC, Fong YC and Tang CH: Cyr61 increases migration and
MMP-13 expression via alphavbeta3 integrin, FAK, ERK and
AP-1-dependent pathway in human chondrosarcoma cells.
Carcinogenesis. 30:258–268. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tarín C, Gomez M, Calvo E, López JA and
Zaragoza C: Endothelial nitric oxide deficiency reduces
MMP-13-mediated cleavage of ICAM-1 in vascular endothelium: A role
in atherosclerosis. Arterioscler Thromb Vasc Biol. 29:27–32. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Daniele A, Zito AF, Giannelli G, Divella
R, Asselti M, Mazzocca A, Paradiso A and Quaranta M: Expression of
metalloproteinases MMP-2 and MMP-9 in sentinel lymph node and serum
of patients with metastatic and non-metastatic breast cancer.
Anticancer Res. 30:3521–3527. 2010.PubMed/NCBI
|
|
25
|
Määtta M, Talvensaari-Mattila A,
Turpeenniemi-Hujanen T and Santala M: Matrix metalloproteinase-2
(MMP-2) and −9 (MMP-9) and their tissue inhibitors (TIMP-1 and
TIMP-2) in differential diagnosis between low malignant potential
(LMP) and malignant ovarian tumours. Anticancer Res. 27:2753–2758.
2007.PubMed/NCBI
|
|
26
|
Roomi MW, Kalinovsky T, Niedzwiecki A and
Rath M: Modulation of uPA, MMPs and their inhibitors by a novel
nutrient mixture in human colorectal, pancreatic and hepatic
carcinoma cell lines. Int J Oncol. 47:370–376. 2015.PubMed/NCBI
|
|
27
|
Kirimlioğlu H, Türkmen I, Başsüllü N,
Dirican A, Karadağ N and Kirimlioğlu V: The expression of matrix
metalloproteinases in intrahepatic cholangiocarcinoma, hilar
(Klatskin tumor), middle and distal extrahepatic
cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma:
Role of matrix metalloproteinases in tumor progression and
prognosis. Turk J Gastroenterol. 20:41–47. 2009.PubMed/NCBI
|
|
28
|
Tang CH, Tan TW, Fu WM and Yang RS:
Involvement of matrix metalloproteinase-9 in stromal cell-derived
factor-1/CXCR4 pathway of lung cancer metastasis. Carcinogenesis.
29:35–43. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Safranek J, Pesta M, Holubec L, Kulda V,
Dreslerova J, Vrzalova J, Topolcan O, Pesek M, Finek J and Treska
V: Expression of MMP-7, MMP-9, TIMP-1 and TIMP-2 mRNA in lung
tissue of patients with non-small cell lung cancer (NSCLC) and
benign pulmonary disease. Anticancer Res. 29:2513–2517.
2009.PubMed/NCBI
|
|
30
|
Yamada T, Oshima T, Yoshihara K, Tamura S,
Kanazawa A, Inagaki D, Yamamoto N, Sato T, Fujii S, Numata K, et
al: Overexpression of MMP-13 gene in colorectal cancer with liver
metastasis. Anticancer Res. 30:2693–2699. 2010.PubMed/NCBI
|
|
31
|
Vogel C, Chan A, Gril B, Kim SB,
Kurebayashi J, Liu L, Lu YS and Moon H: Management of
ErbB2-positive breast cancer: Insights from preclinical and
clinical studies with lapatinib. Jpn J Clin Oncol. 40:999–1013.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ellington AA, Berhow MA and Singletary KW:
Inhibition of Akt signaling and enhanced ERK1/2 activity are
involved in induction of macroautophagy by triterpenoid B-group
soyasaponins in colon cancer cells. Carcinogenesis. 27:298–306.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wollmann W, Goodman ML, Bhat-Nakshatri P,
Kishimoto H, Goulet RJ Jr, Mehrotra S, Morimiya A, Badve S and
Nakshatri H: The macrophage inhibitory cytokine integrates AKT/PKB
and MAP kinase signaling pathways in breast cancer cells.
Carcinogenesis. 26:900–907. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wu K, Xu L, Zhang L, Lin Z and Hou J: High
jagged1 expression predicts poor outcome in clear cell renal cell
carcinoma. Jpn J Clin Oncol. 41:411–416. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
de Seranno S and Meuwissen R: Progress and
applications of mouse models for human lung cancer. Eur Respir J.
35:426–443. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Chen L, Mayer JA, Krisko TI, Speers CW,
Wang T, Hilsenbeck SG and Brown PH: Inhibition of the p38 kinase
suppresses the proliferation of human ER-negative breast cancer
cells. Cancer Res. 69:8853–8861. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Miao Y, Zhang Y, Wan H, Chen L and Wang F:
GABA-receptor agonist, propofol inhibits invasion of colon
carcinoma cells. Biomed Pharmacother. 64:583–588. 2010. View Article : Google Scholar : PubMed/NCBI
|
